Navigation Links
MedQuist Reports First Quarter 2008 Results
Date:5/12/2008

$(0.12) $(0.05)

Diluted $(0.12) $(0.05)

Weighted average shares outstanding:

Basic 37,544 37,484

Diluted 37,544 37,484

MedQuist Inc. and Subsidiaries

Consolidated Balance Sheets

(In thousands)

(Unaudited)

March 31, December 31,

2008 2007

Assets

Current assets:

Cash and cash equivalents $152,711 $161,582

Accounts receivable, net of allowance of

$4,168 and $4,359, respectively 52,124 48,725

Income tax receivable 737 815

Other current assets 8,109 7,920

Total current assets 213,681 219,042

Property and equipment, net of accumulated

depreciation of $41,184 and $38,772,

respectively 20,197 21,366

Goodwill 125,365 125,505

Other intangible assets, net of accumulated

amortization of $43,234 and $45,209,

respectively 41,721 42,262

Deferred income taxes 2,714 2,712

Other assets 6,830 6,885

Total assets $410,508 $417,772

Liabilities and Shareholders' Equity

Current liabilities:

Accounts payable $10,204 $12,7
'/>"/>

SOURCE MedQuist Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related biology technology :

1. QLT reports initial proof of concept data for punctal plug delivery technology
2. Neurobiological Technologies Reports Third Quarter Financial Results
3. Bionovo Reports First Quarter 2008 Financial Results
4. WorldHeart Reports an Event of Default Under the Note Issued to Abiomed, Resignation of One of Its Board of Directors, and Results of Shareholder Vote at Its Annual Shareholders Meeting
5. Cardium Reports on First Quarter 2008 Highlights and Financial Results
6. Novavax Reports First Quarter 2008 Financial Results
7. Warner Chilcott Reports Operating Results for the Quarter ended March 31, 2008 and Updates 2008 Full Year Guidance
8. Biodel Inc. Reports Second Quarter Fiscal Year 2008 Financial Results
9. Pharmos Corporation Reports 2008 First Quarter Results
10. Halozyme Therapeutics Reports 2008 First Quarter Financial Results
11. Nuvelo Reports First Quarter 2008 Financial Results and Updated Outlook for 2008

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)... Health care employment gre... the only one to show consistent growth during the...spitals remain in trouble, and health systems are ...rsonnel, instead of just administrators. , ...lth care employment continued growing in October d...
(Date:11/24/2009)..., SANMATEO,Calif.,Nov.24/PRNewswire-FirstCall/--...mpanyfocusedondevelopingandcommercializingnovelpai...nno,PresidentandChiefExecutiveOfficer,isscheduledt...rence,tobeheldDecember1-2,2009atTheNewYorkPalaceHo...iglieri,ChiefFinancialOfficer,willbeavailabletores...
(Date:11/24/2009)... The FBI recently approved th...tories participating in or generating DNA records ... Madison, WI USA (PRWEB) -- The FBI rec...ystem for use by laboratories participating in, o...ex System (NDIS). NDIS currently contains more tha...
(Date:11/24/2009)..., DUBLIN,November24/PRNewswire-FirstCall/--Shire...pharmaceuticalcompany,today,announcedthatithassubm...rasealfa,thecompany,senzymereplacementtherapyindev...isthethirdmarketing,applicationforvelaglucerasealf...eUnitedStatesandCanada. , Basedonaglobalsuppl...
Breaking Biology Technology:The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 2The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 3The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 4NeurogesX to Present at Piper Jaffray Health Care Conference 2NeurogesX to Present at Piper Jaffray Health Care Conference 3NDIS Approval of Promega PowerPlex Kit Clears Path for More DNA Profiles to be Added to U.S. Database 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 3
...., March 31 Watson Pharmaceuticals, Inc. (NYSE: ..., announced today that the United States District ...Watson,s generic version of Concerta (methylphenid...ot infringe United States Patent No. 6,919,373 (th.... The opinion, dated March 30, 2009, was issued b...
...ologics announces the filing of two important prov...h 31 Quantum Immunologics, Inc. (QI), a Florida-b... has recently filed two provisional patent applica...py. , , The company,s research is focused on the...cifically, iLRP - immature Laminin Receptor Protei...
...March 31 ArunA Biomedical, Inc., a leader in huma...today that it has been awarded a Department of Def...r utilizing its human stem cell technology. , ,...080819/CLTU003LOGO ) , , The company will furth...lular model for use in a prototype biosensor devel...
Other Biology Technology:Delaware Court Rules That Watson Does Not Infringe Patent Related to Generic Version of Concerta(R) and Declares Patent Invalid 2Immunotherapy-Based Provisional Patents Mark Significant Discovery 2Immunotherapy-Based Provisional Patents Mark Significant Discovery 3ArunA Biomedical Awarded Department of Defense Contract to Further Develop Environmental Biosensor for National Security 2
(Date:11/23/2009)... University of Alabama at Birmingham (UAB) researc...ing medical conditions (co-morbidity) do not expla...mericans compared to Caucasians who also have colo... Cancer , a journal of the American Cancer Societ... co-morbidity are independent predictors of poor s...
(Date:11/23/2009)... existed for 360 million years and survived when t...hreatening to make many of them extinct, according...ogy Today . , The fungus, Batrachochytrium den...waves of amphibian extinctions in Central America ...cts over 350 amphibian species by penetrating thei...
(Date:11/23/2009)...ronmental irritants such as air pollution and ciga...lished today in the American Journal of Respirato... study, from Imperial College London and the Unive... the lungs that can trigger coughing when a person...ey suggest that their findings may ultimately lead...
Breaking Biology News(10 mins):Racial disparity in colon cancer survival not easily explained, UAB researchers say 2Research reveals exactly how coughing is triggered by environmental irritants 2AEterna Zentaris Receives US 245 5 Million from Institutional Investors 14577 1AEterna Zentaris Receives US 245 5 Million from Institutional Investors 14577 2AEterna Zentaris Receives US 245 5 Million from Institutional Investors 14577 3Gauze based NPWT Capable of Achieving Same Treatment Goals as Foam based NPWT 5665 1Gauze based NPWT Capable of Achieving Same Treatment Goals as Foam based NPWT 5665 2Gauze based NPWT Capable of Achieving Same Treatment Goals as Foam based NPWT 5665 3Gauze based NPWT Capable of Achieving Same Treatment Goals as Foam based NPWT 5665 4Governor Rendell Says Hundreds of Jobs Coming to York County as Medical Device Manufacturer Prepares to Expand 5662 1Governor Rendell Says Hundreds of Jobs Coming to York County as Medical Device Manufacturer Prepares to Expand 5662 2Governor Rendell Says Hundreds of Jobs Coming to York County as Medical Device Manufacturer Prepares to Expand 5662 3
...to resist the effects of cheap and popular antivir...tionary tale about U.S. plans to use the antiviral...ction in humans, scientists say. , Researchers an...nza strains to document where and when the virus d...called adamantanes and how far resistant strains s...
...xposed to low temperatures develop more blood vess...t more quickly, according to a new study from Karo...w to control blood vessel development in humans in...th of fat cells and their metabolism depend on oxy...egulate the amount of body fat in order, for inst...
...more efficient that exploits the inertia of a wind...d speed variation, according to research published...s . , Wind power is being touted as a clean and i...he wind is intermittent and so the power output of...smooth these power fluctuations usually involve th...
Other Biology News:Study: Excessive use of antiviral drugs could aid deadly flu 2Study: Excessive use of antiviral drugs could aid deadly flu 3Study: Excessive use of antiviral drugs could aid deadly flu 4Study: Excessive use of antiviral drugs could aid deadly flu 5Tilting at wind farms 2
Vybrant Apoptosis Assay Kit #7 - Hoechst 33342/YO-PRO-1/propidium iodide - 200 assays from Molecular Probes (Invitrogen)
Rat TIMP-1 ELISA Kit from R&D Systems
Human Embryonic Stem Cell Marker Antibody Panel. Contains 25 g each of anti-Alkaline Phosphatase, anti-Nanog, anti-Oct-3/4, anti-SSEA-1, and anti-SSEA-4. from R&D Systems
HSV 1 IgG ELISA Kit from Biomeda Corporation
Biology Products: